Ringaskiddy, Ireland
Pfizer completed construction of the Monoclonal Antibodies Small Scale Facility in October of 2010 in Ringaskiddy, Ireland. The cGMP facility will manufacture, purify, formulate, and bulk fill mammalian culture derived proteins for clinical trials. Establishing a biotechnology manufacturing center of excellence, the Small Scale Facility provides 5,500 liters of bioreactor capacity. The architect for the sustainably designed project was Fluor of Greenville, S.C., with Jacobs Engineering as construction manager.
